CX08005
CAS No. 1256341-22-6
CX08005( —— )
Catalog No. M34923 CAS No. 1256341-22-6
CX08005 is a protein tyrosine phosphatase 1B inhibitor. CX08005 reduces hepatic lipid accumulation and microcirculatory impairment associated with non-alcoholic fatty liver disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 216 | In Stock |
|
| 10MG | 334 | In Stock |
|
| 25MG | 630 | In Stock |
|
| 50MG | 871 | In Stock |
|
| 100MG | 1172 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2344 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCX08005
-
NoteResearch use only, not for human use.
-
Brief DescriptionCX08005 is a protein tyrosine phosphatase 1B inhibitor. CX08005 reduces hepatic lipid accumulation and microcirculatory impairment associated with non-alcoholic fatty liver disease.
-
DescriptionCX08005 is a competitive PTP1B inhibitor. CX08005 can directly enhance the action of insulin in vivo and in vitro and improve insulin resistance.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1256341-22-6
-
Formula Weight453.61
-
Molecular FormulaC28H39NO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C(=O)C1=C(C(O)=O)C=CC=C1)C2=C(OCCCCCCCCCCCCCC)C=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
PTP Inhibitor II
PTP inhibitor II is an ?inhibitor of cell-permeable protein tyrosine phosphatase (PTP) that covalently binds the catalytic domain of the Src homology region 2 domain-containing phosphatase (SHP-1(ΔSH2))with Ki of128 μM.
-
LUPENONE
Lupenone is a natural product isolated from Rhizoma Musae and has good anti-diabetic activityand has anti-inflammatory activity.lupenone were potent PTP1B inhibitors with IC50 values of 15.11±1.23μM.
-
LFHP-1c
LFHP-1c is a novel PGAM5 inhibitor that shows neuroprotective activity in an ischemic stroke model, preventing BBB destruction after transient middle cerebral artery occlusion (tMCAO) in rats.LFHP-1c can be used to study cerebral ischemic stroke.
Cart
sales@molnova.com